All Type of News
100 drug makers to bring fight to a court
The debate over slashing drug prices this year will be brought to a court, with a suit to nullify the government’s plans to cut the price of about half the drugs on the market by an average of 14 percent.
The Korea...
EMA approves new antimalarial drug developed by Shinpoong
Shinpoong Pharmaceutical Co. said Monday that the European Medicines Agency (EMA) approved a new artemisinin based combination therapy (ACT) Pyramax for treatment of malaria.
Co-developed by Switzerland based Medic...
FDA guidelines for biosimilar biotech drugs are positive to Korean drug makers
The US Food and Drug Administration (FDA) has come up with guidelines for the sale of lower-cost versions of biotechnology drugs, issued on Thursday.
“These draft documents are designed to help the Korean drug indu...
Korea-U.S. FTA likely to go into effect soon
The government said it hopes for the implementation of a free trade agreement (FTA) between Korea and the U.S. at an earlier date.
“Korea’s FTA representative Choi Suk-young and Wendy Cutler, the chief negotiator f...
Korean impotence drugs increase market share
Korean-made erectile dysfunction drugs are expected to secure more market share in Korea
Encouraged by robust sales, SK Chemicals and JW Pharmaceutical are stepping up their marketing in the domestic erectile dysfunc...
640 essential medicines to exempt from price-cut plan
A total of 640 essential drugs, including amino acid infusions, will be excluded from the government’s plan to slash the price of about half the drugs on the market by an average of 14 percent from April, according to...
Gastritis patients growing
A growing number of Koreans are experiencing gastritis, a condition in which the stomach lining—known as the mucosa—is inflamed, health officials said recently.
According to the National Health Insurance Corporatio...
Huons profits increase 1,185% in 2011
Huons Pharma’s last year sales increased by 12 percent, while its operating profits for the period increased by 1,185 percent compared to the same period last year.
The company’s sales figure for the period came in...
Dong-A drooling over future profits
The imminent additional reclassification of 20 over-the-counter (OTC) drugs as “quasi-drugs,” is seen as a much needed move for the industry, but not everyone is going to benefit from it.
A parliamentary health sub...
State-run health insurance sees huge surplus in 2011
After fears that its reserves would be depleted in a not-too-distant future, the national health insurance fund was 600.8 billion won in the black last year and had 1.56 trillion won in reserves.
The National Healt...
